Notably, LIPT1’s putative role in impeding NSCLC progression is hypothesized to be mediated via the modulation of the copper chaperone gene ATOX1, a claim substantiated by cellular assays. This evidence concerns the gene ATOX1 and non-small cell lung carcinoma.